Black Rock Inc. Adamis Pharmaceuticals Corp Transaction History

Black Rock Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.1 - $0.3 $87 - $261	-870 Reduced 0.03%	2,766,939 $332,000
Q4 2022 Feb 13, 2023	SELL	$0.14 - $0.22 $155 - $244	-1,110 Reduced 0.04%	2,767,809 $470,000
Q3 2022 Nov 14, 2022	SELL	$0.24 - $0.54 $4,352 - $9,792	-18,135 Reduced 0.65%	2,768,919 $549,000
Q2 2022 Aug 12, 2022	BUY	$0.34 - $0.57 $1,729 - $2,900	5,088 Added 0.18%	2,787,054 $1.4 Million
Q1 2022 May 12, 2022	BUY	$0.55 - $0.73 $14,930 - $19,817	27,147 Added 0.99%	2,781,966 $1.59 Million
Q4 2021 Feb 10, 2022	BUY	$0.57 - $1.23 $5,931 - $12,800	10,407 Added 0.38%	2,754,819 $1.67 Million
Q3 2021 Nov 09, 2021	BUY	$0.92 - $1.18 $1,760 - $2,258	1,914 Added 0.07%	2,744,412 $2.66 Million
Q2 2021 Aug 11, 2021	BUY	$0.66 - $1.23 $1.81 Million - $3.37 Million	2,742,498 New	2,742,498 $3.02 Million

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.